![Ulrich Granzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulrich Granzer
Directeur Général chez
Granzer Regulatory Consulting & Services
Profil
Ulrich Granzer is the founder of Granzer Regulatory Consulting & Services, which was founded in 2002.
He is currently the Director at Cardior Pharmaceuticals GmbH, a Venture Partner at Wellington Partners GmbH since 2004, and a Member-Supervisory Board at APEIRON Biologics AG since 2021.
Dr. Granzer previously served as the Chairman-Supervisory Board at Biofrontera AG from 2016 to 2021.
He also held positions as Director of Regulatory Affairs at Bayer AG, GSK Plc, and Knoll AG.
Additionally, he was a Director-Supervisory Board at Immatics Biotechnologies GmbH from 2009 to 2012 and Head of Regulatory Affairs at Bayer Pharma AG.
Dr. Granzer holds a doctorate degree from Eberhard Karls Universität Tübingen and a graduate degree from Philipps University of Marburg.
Postes actifs de Ulrich Granzer
| Sociétés | Poste | Début |
|---|---|---|
Granzer Regulatory Consulting & Services | Directeur Général | 01/01/2002 |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Private Equity Investor | 01/01/2004 |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Directeur/Membre du Conseil | - |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases | Directeur/Membre du Conseil | 21/06/2021 |
Anciens postes connus de Ulrich Granzer
| Sociétés | Poste | Fin |
|---|---|---|
| BIOFRONTERA AG | Président | 14/12/2021 |
| BAYER AG | Conseiller Juridique Général | - |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Conseiller Juridique Général | - |
| GSK PLC | Conseiller Juridique Général | - |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Conseiller Juridique Général | - |
Formation de Ulrich Granzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor. | Finance |
Biofrontera AG
 Biofrontera AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops and distributes dermatological products | Health Technology |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases | Health Technology |
Granzer Regulatory Consulting & Services | |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts | Health Technology |
